GIP

DRUG13 trials

Sponsors

National Institute on Aging (NIA), Mikkel Christensen, Rigshospitalet, Denmark, University of Pennsylvania, University of Nottingham

Conditions

Cystic FibrosisDiabetes Mellitus, Type 1Effect of iv Administration of GIP and AlanineExtra-pancreatic Incretin EffectGlucose EffectivenessHealhtyHealthyHypoglycemia

Phase 1

GIP: Glucose-dependent Insulinotropic Peptide

CompletedNCT00239707

National Institute on Aging (NIA)Type 2 Diabetes

Start: 2003-02-28End: 2006-12-31Updated: 2013-11-28

The Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Healthy Individuals

RecruitingNCT06419686

University Hospital, Gentofte, CopenhagenEffect of iv Administration of GIP and Alanine

Start: 2024-01-01End: 2024-07-31Target: 10Updated: 2024-05-17

Unknown Phase

GIP and GLP-1 in Type 1 Diabetes

CompletedNCT01739283

Mikkel ChristensenHypoglycemia

Start: 2012-07-31End: 2013-11-30Updated: 2015-07-13

Hyperglycemia and the Extra-pancreatic Effect of Incretins

CompletedNCT01749163

Rigshospitalet, DenmarkExtra-pancreatic Incretin Effect, Glucose Effectiveness

Start: 2012-09-30End: 2014-03-31Updated: 2014-12-03

Beta-cell Response to Incretin Hormones in Cystic Fibrosis

RecruitingNCT01851694

University of PennsylvaniaCystic Fibrosis, Pancreatic Insufficiency

Start: 2013-05-31End: 2026-12-31Target: 45Updated: 2026-01-14

Characterizing the Incretin Effect of Amino Acids and Defining GLP-1 Role on Skeletal Muscle

CompletedNCT02370745

University of NottinghamSarcopenia

Start: 2014-11-30End: 2018-03-31Updated: 2018-05-02

Glucose-Dependent Insulinotropic Polypeptide - Effects on Markers of Bone Turnover in Patients With Type 1 Diabetes

CompletedNCT03195257

Mikkel ChristensenType 1 Diabetes Mellitus

Start: 2012-11-17End: 2016-12-01Updated: 2017-06-23

Gut Hormones and Bone Remodeling in Humans (KS-2)

CompletedNCT03573934

University of CopenhagenHealthy

Start: 2017-09-15End: 2018-03-15Updated: 2020-01-18

Effects of a Liquid Meal and Gut Hormones (GIP and GLP-2) on Bone Remodeling in Participants With Hypoparathyroidism.

CompletedNCT03728959

University of CopenhagenHypoparathyroidism

Start: 2018-09-12End: 2019-04-12Updated: 2019-12-12

The Role of Glucose-Dependent Insulinotropic Polypeptide in the Pathological Glucose Homeostasis Of Type 1 Diabetes

CompletedNCT03734718

Steno Diabetes Center CopenhagenDiabetes Mellitus, Type 1, Hypoglycemia

Start: 2019-06-01End: 2019-12-31Updated: 2020-01-27

Effects of Gut Peptides on Bone Remodeling. KS-4-Diabetes-19

CompletedNCT03867656

University of CopenhagenType 2 Diabetes Mellitus

Start: 2019-02-26End: 2020-06-26Updated: 2020-11-04

Gut Peptides and Bone Remodeling in Individuals With Spinal Cord Injury

University of CopenhagenSpinal Cord Injuries

Start: 2021-11-16End: 2024-11-30Target: 20Updated: 2023-05-10

Insulin-Mediated Glucose Uptake and Organ Perfusion Assessed by Total-Body PET During GIP and GLP-1 Infusion

RecruitingNCT07398300

Rigshospitalet, DenmarkHealhty, Type 2 Diabetes

Start: 2026-03-12End: 2027-05-01Target: 36Updated: 2026-02-09

Related Papers

Cholesin mRNA Expression in Human Intestinal, Liver, and Adipose Tissues

Nutrients2025-02-081 citations

The effect of 6-day subcutaneous glucose-dependent insulinotropic polypeptide infusion on time in glycaemic range in patients with type 1 diabetes: a randomised, double-blind, placebo-controlled crossover trial.

2021-08-177 citations